Novel Mycobacterium tuberculosis thioredoxin reductase inhibitors with antimycobacterial activity in infected macrophages that overcomes problems of current anti-tuberculotics.
[Detail]
PPI-benzimidazole analogues for the treatment of multidrug-resistant tuberculosis.
[Detail]
PPI-benzimidazole analogues for the treatment of multidrug-resistant tuberculosis.
[Detail]